EpiPen Maker Mylan Pharma Expands March Recall of Auto-Injectors

The EpiPen intervention product administers doses of epinephrine to patients suffering from anaphylaxis resulting from extreme allergic reactions. These reactions, of course, can be fatal if left untreated and, which makes the EpiPen product special and very important. EpiPen is…

Novocure Glioblastoma Treatment Trial Shows Extremely Promising Results

A company known as Novocure markets a wearable medical device aimed at treating brain cancer. Recently, the company finished its phase 2 pilot trial for the noninvasive therapy in patients who have pancreatic cancer. Given along with two chemotherapy drugs,…


Democratizing access to all financial data. Cutting edge web platform for news and information.

Disclaimer: StocksBeat inform you that the data in this website is not necessarily real-time nor accurate. All prices are not provided by exchanges and prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Stocksbeat doesn`t bear any responsibility for any trading losses you might incur as a result of using the data.